Any thought on if they will announce the submittal of phase 3 for Tesetaxel first and then do the R/S? Or do the R/S then announce the phase 3?
"Genta plans to submit its proposed Phase 3 trial to FDA in the 2nd-quarter in order to secure a Special Protocol Assessment (SPA)".
Well 2nd quarter is pretty much over....
I would like to average down some (not a bad pps but down). Just trying to time it right. PPS tends to fall right after R/S, so I'm thinking cheaper shares. However, a different story last yr b/c of the positivity leading into the Genasense meeting with FDA.
Market Data 
Markets 
AI
